- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 52.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 54.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 53.83M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $28.88M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$53.36M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $329.46M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $307.53M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $417.94M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $312.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $280.47M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $32.52M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $40.84M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $37.28M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $46.33M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $339.2M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $315.19M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $349.89M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $326.8M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.60 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.61 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.12 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $12.67M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $17.6M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $12.63M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $50.81M |
| Net Income | Q1 2026 · Mar 31, 2026 | $32.72M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$60.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $30.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$65.58M |
| Revenue | Q1 2026 · Mar 31, 2026 | $51.08M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.83M |